[HTML][HTML] Magnesium in prevention and therapy

U Gröber, J Schmidt, K Kisters - Nutrients, 2015 - mdpi.com
Magnesium is the fourth most abundant mineral in the body. It has been recognized as a
cofactor for more than 300 enzymatic reactions, where it is crucial for adenosine …

[HTML][HTML] Vegetable-based diets for chronic kidney disease? It is time to reconsider

A Cases, S Cigarrán-Guldrís, S Mas, E Gonzalez-Parra - Nutrients, 2019 - mdpi.com
Traditional dietary recommendations to renal patients limited the intake of fruits and
vegetables because of their high potassium content. However, this paradigm is rapidly …

[HTML][HTML] Hyperphosphatemia and cardiovascular disease

C Zhou, Z Shi, N Ouyang, X Ruan - Frontiers in Cell and …, 2021 - frontiersin.org
Hyperphosphatemia or even serum phosphate levels within the “normal laboratory range”
are highly associated with increased cardiovascular disease risk and mortality in the general …

[HTML][HTML] Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation

AD Ter Braake, PT Tinnemans, CM Shanahan… - Scientific reports, 2018 - nature.com
Magnesium has been shown to effectively prevent vascular calcification associated with
chronic kidney disease. Magnesium has been hypothesized to prevent the upregulation of …

Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification

AD Ter Braake, C Eelderink, LW Zeper… - Nephrology Dialysis …, 2020 - academic.oup.com
Abstract Background Phosphate (Pi) toxicity is a strong determinant of vascular calcification
development in chronic kidney disease (CKD). Magnesium (Mg2+) may improve …

[HTML][HTML] Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg2+ homeostasis and cytoskeletal architecture

S Stritt, P Nurden, R Favier, M Favier, S Ferioli… - Nature …, 2016 - nature.com
Mg2+ plays a vital role in platelet function, but despite implications for life-threatening
conditions such as stroke or myocardial infarction, the mechanisms controlling [Mg2+] i in …

Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis

J Xiong, T He, M Wang, L Nie, Y Zhang, Y Wang… - Journal of …, 2019 - Springer
Background Previous studies reported that magnesium deficiency was associated with
vascular calcifications, atherosclerosis and cardiovascular disease, which might play an …

PGE2, kidney disease, and cardiovascular risk: beyond hypertension and diabetes

R Nasrallah, R Hassouneh… - Journal of the American …, 2016 - journals.lww.com
An important measure of cardiovascular health is obtained by evaluating the global
cardiovascular risk, which comprises a number of factors, including hypertension and type 2 …

[HTML][HTML] Oral magnesium supplementation in chronic kidney disease stages 3 and 4: efficacy, safety, and effect on serum calcification propensity—a prospective …

I Bressendorff, D Hansen, M Schou, B Silver… - Kidney international …, 2017 - Elsevier
Introduction Chronic kidney disease (CKD) is associated with high cardiovascular morbidity
and mortality. Recent evidence suggests that increases in both serum and intracellular …

Measuring magnesium–Physiological, clinical and analytical perspectives

A Dent, R Selvaratnam - Clinical Biochemistry, 2022 - Elsevier
Magnesium is the fourth most abundant cation in the human body, essential for
physiological processes and is the electrolyte with levels commonly deranged in critically ill …